2004

The world's first SARS inactivated vaccine Phase I clinical study results was unblinded

Started study on pandemic influenza vaccine against human infection with highly pathogenic avian influenza (H5N1)

SINOVAC shares were listed on the American Stock Exchange (AMEX)